Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 30.64x is in line with its estimated 1-year average of 33.01x, near the low end of its estimated 1-year range (30.42x–35.70x).
As of 2026-10-06T16:43:30.758Z.
Calculation as of: 2026-10-06T16:43:30.758Z.
Quote observation: 2026-10-06T16:40:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 347a41eedf46a91d1f1a35dde2c997a021a555167078676fef94c90a8032fb0d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
30.64x
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.54x
median of 203 covered companies
CURRENT VS SECTOR MEDIAN
+97.17%
vs the sector median at left
MiniMed Group, Inc. Common Stock
Market Cap
$5.51B
EV/EBITDA Ratio
30.64x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.32B
EV/EBITDA Ratio
28.93x
TTM Avg
14.09x
3Y Avg
107.60x
5Y Avg
107.60x
Market Cap
$5.74B
EV/EBITDA Ratio
54.66x
TTM Avg
88.38x
3Y Avg
133.43x
5Y Avg
103.02x
Market Cap
$5.28B
EV/EBITDA Ratio
12.55x
TTM Avg
12.96x
3Y Avg
13.18x
5Y Avg
14.62x
Market Cap
$5.20B
EV/EBITDA Ratio
N/A
TTM Avg
12.99x
3Y Avg
275.14x
5Y Avg
275.14x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $5.51B | 30.64x | N/A | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.54B | 21.74x | 24.95x | 22.12x | 17.84x |
| Doximity, Inc. (DOCS)vs › | $5.33B | 23.92x | 26.05x | 37.20x | 51.94x |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 28.93x | 14.09x | 107.60x | 107.60x |
| CG Oncology Inc. (CGON)vs › | $5.71B | N/A | N/A | N/A | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.74B | 54.66x | 88.38x | 133.43x | 103.02x |
| Sotera Health Company (SHC)vs › | $5.28B | 12.55x | 12.96x | 13.18x | 14.62x |
| Cogent Biosciences, Inc. (COGT)vs › | $5.21B | N/A | N/A | N/A | N/A |
| CRISPR Therapeutics AG (CRSP)vs › | $5.20B | N/A | 12.99x | 275.14x | 275.14x |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.93B | 44.83x | 617.82x | 545.60x | 321.06x |
At 30.6, EV/EBITDA is below its estimated 1-year median — higher than 11% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
30.4
median
33.1
estimated 1-year high
35.7
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 31.53x |
| 2026-10-02 | 30.79x |
| 2026-10-01 | 30.63x |
| 2026-09-30 | 30.42x |
| 2026-09-29 | 31.33x |
| 2026-09-28 | 32.06x |
| 2026-09-25 | 31.24x |
| 2026-09-24 | 31.98x |
| 2026-09-23 | 32.14x |
| 2026-09-22 | 33.20x |
| 2026-09-21 | 33.07x |
| 2026-09-18 | 34.14x |
| 2026-09-17 | 34.53x |
| 2026-09-16 | 35.12x |
| 2026-09-15 | 34.50x |
| 2026-09-14 | 34.43x |
| 2026-09-11 | 35.28x |
| 2026-09-10 | 35.19x |
| 2026-09-09 | 35.70x |
